Small cell carcinoma of the esophagus. The memorial hospital experience 1970 to 1987
β Scribed by Gwen L. Nichols; David P. Kelsen
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 259 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
During the period 1970 to 1987, 11 patients with small cell carcinoma of the esophagus were treated at Memorial Sloan-Kettering Cancer Center, New York. This rare tumor was responsible for 1.1% of all patients with esophageal tumors seen on the inpatient services during that period. Using a clinical staging system similar to that employed in small cell cancer of the lung, eight of 11 patients had extensive disease. Although responses were seen to multidrug combination chemotherapy regimens used alone or with sequential radiation, the overall prognosis for small cell esophageal cancer was poor, with a median survival of 7.5 months. Only one patient lived for greater than 2 years.
π SIMILAR VOLUMES
Small-cell carcinoma of the esophagus is a rare tumor. In most reported cases, surgery has been the major mode of therapy. Most patients have relapsed rapidly with disseminated disease. We treated a patient with small-cell carcinoma of the esophagus with a multi-drug regimen being used in small cell
## Background: Small cell carcinoma of the esophagus is a rare disease with aggressive behavior and poor prognosis. multidrug chemotherapy remains the treatment of choice given the systemic nature of the disease. radiotherapy has been used concurrently with chemotherapy to enhance local control. th
prognostic factors that influenced survival, the patients were grouped according to limited stage (LS), which was defined as disease confined to the esophagus, Radiation Oncology Department, Hospital Clinic or extensive stage (ES), which was defined as disease that had spread beyond i Provincial, Ba